DBV Technologies (DBVT) Profit After Tax (2020 - 2026)

DBV Technologies (DBVT) posted quarterly Profit After Tax of -$51.2 million for Q2 2026, down 22.2% year-on-year from -$65.8 million in Q2 2025, and down 7.56% on a QoQ basis from -$47.6 million in Q1 2026.

DBV Technologies (DBVT) Profit After Tax (2020 - 2026) Analysis & Trends

DBV Technologies (DBVT) has reported Profit After Tax for 7 consecutive years, with -$51.2 million the latest figure, recorded in Q2 2026.

  • Quarterly Profit After Tax fell 22.2% year-over-year to -$51.2 million in Q2 2026, while the trailing twelve-month figure through Jun 2026 was -$177.6 million (down 40.66% YoY) and the FY2025 annual result came in at -$146.9 million, down 24.56% from the prior year.
  • Profit After Tax eased to -$51.2 million in Q2 2026 per DBVT's latest filing, from -$47.6 million in the prior quarter.
  • Over the last five years, Profit After Tax for DBVT reached as high as -$10.6 million in Q4 2023 and fell as low as -$51.2 million in Q2 2026.
  • A 5-year average of -$29.5 million and a median of -$27.2 million in 2024 frame the typical range for Profit After Tax.
  • Annual changes were most pronounced in 2023 — Profit After Tax jumped 43.9% — and 2024, when it slumped 152.84%.
  • Year by year, Profit After Tax stood at -$18.9 million in 2022, then soared by 43.9% to -$10.6 million in 2023, then sank by 152.84% to -$26.8 million in 2024, then tumbled by 67.03% to -$44.8 million in 2025, then decreased by 14.21% to -$51.2 million in 2026.
  • According to Business Quant data, Profit After Tax over the past three periods registered -$51.2 million, -$47.6 million, and -$44.8 million for Q2 2026, Q1 2026, and Q4 2025 respectively.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) PAT (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -36.84 Mn
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 227.36 Mn
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1.03 Bn
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -65.60 Mn
7 Belite Bio 62.51 Bn 62.51 Bn - -26.94 Mn
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 362.00 Mn
9 Revolution Medicines 37.78 Bn 37.78 Bn - -453.82 Mn
10 DBV Technologies 267.50 Mn 92.60 Mn - -51.20 Mn

Historic Data

Download Data
DateValue
Jun 30, 2026 -51.20 Mn
Mar 31, 2026 -47.60 Mn
Dec 31, 2025 -44.83 Mn
Sep 30, 2025 -34.00 Mn
Jun 30, 2025 -41.90 Mn
Mar 31, 2025 -27.10 Mn
Dec 31, 2024 -26.84 Mn
Sep 30, 2024 -30.44 Mn
Jun 30, 2024 -33.12 Mn
Mar 31, 2024 -27.35 Mn
Dec 31, 2023 -10.62 Mn
Sep 30, 2023 -20.66 Mn
Jun 30, 2023 -24.24 Mn
Mar 31, 2023 -20.56 Mn
Dec 31, 2022 -18.92 Mn
Sep 30, 2022 -32.67 Mn
Jun 30, 2022 -23.04 Mn
Mar 31, 2022 -16.71 Mn
Dec 31, 2021 -16.24 Mn
Sep 30, 2021 -27.73 Mn